GGA3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.605800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.483800E-01
Normal-vs-Stage2
4.661000E-01
Normal-vs-Stage3
3.699800E-01
Normal-vs-Stage4
4.516800E-01
Stage1-vs-Stage2
7.863600E-01
Stage1-vs-Stage3
4.205000E-01
Stage1-vs-Stage4
9.767400E-01
Stage2-vs-Stage3
2.638400E-01
Stage2-vs-Stage4
8.475600E-01
Stage3-vs-Stage4
4.125600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.571600E-01
Normal-vs-AfricanAmerican
4.784000E-01
Normal-vs-Asian
4.887000E-01
Caucasian-vs-AfricanAmerican
8.677800E-01
Caucasian-vs-Asian
6.898200E-01
AfricanAmerican-vs-Asian
9.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.526600E-01
Normal-vs-Female
4.711200E-01
Male-vs-Female
5.472000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.106400E-01
Normal-vs-Age(41-60Yrs)
4.917000E-01
Normal-vs-Age(61-80Yrs)
4.444800E-01
Normal-vs-Age(81-100Yrs)
4.558800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.186800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.188600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.395600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.319190E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.893600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.848400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.466600E-01
Normal-vs-Daily Drinker
4.114800E-01
Normal-vs-Weekly Drinker
4.501000E-01
Normal-vs-Occasional Drinker
4.731400E-01
Normal-vs-Social Drinker
5.158400E-01
Non Drinker-vs-Daily Drinker
5.426200E-01
Non Drinker-vs-Weekly Drinker
9.796200E-01
Non Drinker-vs-Occasional Drinker
7.124600E-01
Non Drinker-vs-Social Drinker
3.678400E-01
Daily Drinker-vs-Weekly Drinker
5.563400E-01
Daily Drinker-vs-Occasional Drinker
3.159400E-01
Daily Drinker-vs-Social Drinker
1.034770E-01
Weekly Drinker-vs-Occasional Drinker
7.611000E-01
Weekly Drinker-vs-Social Drinker
4.164800E-01
Occasional Drinker-vs-Social Drinker
5.890200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.449030E-01
Normal-vs-Grade 2
4.522100E-02
Normal-vs-Grade 3
2.286100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.967800E-01
Grade 1-vs-Grade 3
6.095400E-01
Grade 1-vs-Grade 4
1.449030E-01
Grade 2-vs-Grade 3
9.378600E-01
Grade 2-vs-Grade 4
4.522100E-02
Grade 3-vs-Grade 4
2.286100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.215200E-01
Normal-vs-NonDiabetic
4.697200E-01
Diabetic-vs-NonDiabetic
1.836010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.220400E-01
Normal-vs-NoPancreatitis
4.429600E-01
Pancreatitis-vs-NoPancreatitis
2.373400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.828000E-01
Normal-vs-N1
4.515800E-01
N0-vs-N1
3.743800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.526200E-01
Normal-vs-TP53-NonMutant
4.930400E-01
TP53-Mutant-vs-TP53-NonMutant
3.772600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
